Immunotherapy Options for Nonmetastatic NSCLC

Source: Lung Cancer Immunotherapy: Improving Patient Outcomes Across the Disease Continuum
Download Slideset
Download this slideset from a live CCO symposium for an overview of the key data on immunotherapy options for patients with early-stage resectable and stage III unresectable NSCLC.
Zofia Piotrowska, MD, MHS
Format: Microsoft PowerPoint (.ppt)
File Size: 1.01 MB
Released: November 10, 2022

Acknowledgements

Provided by Clinical Care Options, LLC
Contact Info

Contact Clinical Care Options

For customer support please email: customersupport@cealliance.com

Mailing Address
Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA 20191

Supported by an educational grant from
Regeneron Pharmaceuticals, Inc.

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue

Cookie Settings